Bioequivalence Study Followed by Model Informed Dose Optimization of a Powder for Oral Suspension of 6-Mercaptopurine
Bhavatharini Arun1, Mahendra Joshi2, Archana Khosa Kakkar2, Shivkumar Madki2, Vijay Ivaturi3, Girish Chinnaswamy4,5, Shripad Banavali4,5, Vikram Gota*1,5.
1Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai-410210, Maharashtra, India
2IDRS Labs Pvt Ltd., Bengaluru, Karnataka, India
3Pumas AI, Inc., Centreville, Virginia, USA.
4Department of Paediatric Oncology, Tata Memorial Hospital, Mumbai- 400012, India
5Homi Bhabha National Institute, Anushakthinagar, Mumbai- 400094, India.
*Corresponding author:
Dr. Vikram Gota
Professor, Department of Clinical Pharmacology,
Advanced Centre for Treatment, Research and Education in Cancer,
Tata Memorial Centre, Navi Mumbai- 410210
Fax: +91 22 740 5061
Phone: +91 22 2740 5493
Email: vgota76@gmail.com